Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALMOTRIPTAN MALATE vs ALOGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALMOTRIPTAN MALATE vs ALOGLIPTIN: Safety Overview

Metric ALMOTRIPTAN MALATE ALOGLIPTIN
Total FAERS Reports 497 1,385
Deaths Reported 3 122
Death Rate 0.6% 8.8%
Hospitalizations 60 567
Average Patient Age 52.4 yrs 69.0 yrs
% Female Patients 16.5% 41.0%
FDA Approval Date Jul 7, 2015 Jan 25, 2013
Manufacturer Mylan Pharmaceuticals Inc. Padagis Israel Pharmaceuticals Ltd
Route ORAL ORAL
Marketing Status Discontinued Prescription